The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time to response, duration of response, and patient-reported outcomes (PROs) with daratumumab (DARA) plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) alone in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM): Subgroup analysis of the phase 3 MAIA study.
 
Thierry Facon
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Janssen (Inst); Roche (Inst); Takeda (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Janssen (Inst)
 
Shaji Kumar
Honoraria - BeiGene
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Torben Plesner
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Genmab; Janssen; Oncopeptides; Takeda
Speakers' Bureau - Janssen; Takeda
Research Funding - Abbvie (Inst); Celgene (Inst); Genentech (Inst); Genmab (Inst); Janssen; Oncopeptides (Inst); Roche (Inst); Takeda (Inst)
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Hartmut Goldschmidt
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Chugai Pharma; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma Europe (Inst); Incyte (Inst); Janssen (Inst); Molecular Partners (Inst); MSD (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi
Other Relationship - Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Sanofi (Inst)
 
Michael O'Dwyer
Employment - ONK Therapeutics
Leadership - ONK Therapeutics
Stock and Other Ownership Interests - ONK Therapeutics
Honoraria - Sanofi
Consulting or Advisory Role - Janssen
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - ONK Therapeutics
Travel, Accommodations, Expenses - ONK Therapeutics
 
Aurore Perrot
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Sanofi; Takeda
 
Christopher P. Venner
Honoraria - Bristol-Myers Squibb; Forus; Janssen; Pfizer; Sanofi
 
Katja Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene (Inst); Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline (Inst); Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Sanofi (Inst); Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
Joseph R. Mace
Employment - Florida Cancer Specialists and Research Institute
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Immuneel Therapeutics; Janssen Oncology; Merck; Pfizer; Takeda
Research Funding - Bluebird Bio (Inst)
 
Mourad Tiab
No Relationships to Disclose
 
Margaret Macro
Consulting or Advisory Role - Amgen; Celgene; Takeda
Research Funding - Janssen medical Affairs (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen Oncology; Janssen-Cilag; Janssen-Cilag; Takeda
 
Laurent Frenzel
No Relationships to Disclose
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Huiling Pei
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Fredrik Borgsten
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Oncopeptides; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics